Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Umbricht

Showing results (31-40 of 72) with videos related to

Pageof 8
Sort By:
Schizophrenia Research|November 22, 2005
Defining subjects at risk for psychosis: a comparison of two approachesAndor E Simon, Diane N Dvorsky, Jakob Boesch, et al.
Schizophrenia Research|January 27, 2009
Subclinical hallucinations in adolescent outpatients: an outcome studyAndor E Simon, Katja Cattapan-Ludewig, Kerstin Gruber, et al.
Human Brain Mapping|March 5, 2021
The effect of risperidone on reward-related brain activity is robust to drug-induced vascular changesPeter C T Hawkins, Fernando O Zelaya, Owen O'Daly, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|September 21, 2010
Prodromal schizophrenia in primary care: a randomised sensitisation studyAndor E Simon, Sabrina Jegerlehner, Thomas Müller, et al.
The Journal of Clinical Psychiatry|April 15, 2026
A Phase 2b Multicenter Study to Evaluate Basmisanil as an Adjunctive Treatment in Patients With Cognitive Impairment Associated With SchizophreniaDaniel Umbricht, Markus Abt, Michael Derks, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 19, 2012
Marked global reduction in mGluR5 receptor binding in smokers and ex-smokers determined by [11C]ABP688 positron emission tomographyFunda Akkus, Simon M Ametamey, Valerie Treyer, et al.
Science Translational Medicine|May 3, 2019
A phase 2 clinical trial of a vasopressin V1a receptor antagonist shows improved adaptive behaviors in men with autism spectrum disorderFederico Bolognani, Marta Del Valle Rubido, Lisa Squassante, et al.
Journal of Autism and Developmental Disorders|May 6, 2020
Correction to: Exploring Social Biomarkers in High‑Functioning Adults with Autism and Asperger's Versus Healthy Controls: A Cross‑Sectional AnalysisMarta Del Valle Rubido, Eric Hollander, James T McCracken, et al.
Autism Research : Official Journal of the International Society for Autism Research|October 17, 2018
In Search of Biomarkers for Autism Spectrum DisorderMarta Del Valle Rubido, James T McCracken, Eric Hollander, et al.
Schizophrenia Bulletin|April 7, 2007
Cognitive functioning in the schizophrenia prodromeAndor E Simon, Katja Cattapan-Ludewig, Solange Zmilacher, et al.
Pageof 8

Showing results (31-40 of 72) with videos related to

Sort By:
Pageof 8
Schizophrenia Research|November 22, 2005
Defining subjects at risk for psychosis: a comparison of two approachesAndor E Simon, Diane N Dvorsky, Jakob Boesch, et al.
Schizophrenia Research|January 27, 2009
Subclinical hallucinations in adolescent outpatients: an outcome studyAndor E Simon, Katja Cattapan-Ludewig, Kerstin Gruber, et al.
Human Brain Mapping|March 5, 2021
The effect of risperidone on reward-related brain activity is robust to drug-induced vascular changesPeter C T Hawkins, Fernando O Zelaya, Owen O'Daly, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|September 21, 2010
Prodromal schizophrenia in primary care: a randomised sensitisation studyAndor E Simon, Sabrina Jegerlehner, Thomas Müller, et al.
The Journal of Clinical Psychiatry|April 15, 2026
A Phase 2b Multicenter Study to Evaluate Basmisanil as an Adjunctive Treatment in Patients With Cognitive Impairment Associated With SchizophreniaDaniel Umbricht, Markus Abt, Michael Derks, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 19, 2012
Marked global reduction in mGluR5 receptor binding in smokers and ex-smokers determined by [11C]ABP688 positron emission tomographyFunda Akkus, Simon M Ametamey, Valerie Treyer, et al.
Science Translational Medicine|May 3, 2019
A phase 2 clinical trial of a vasopressin V1a receptor antagonist shows improved adaptive behaviors in men with autism spectrum disorderFederico Bolognani, Marta Del Valle Rubido, Lisa Squassante, et al.
Journal of Autism and Developmental Disorders|May 6, 2020
Correction to: Exploring Social Biomarkers in High‑Functioning Adults with Autism and Asperger's Versus Healthy Controls: A Cross‑Sectional AnalysisMarta Del Valle Rubido, Eric Hollander, James T McCracken, et al.
Autism Research : Official Journal of the International Society for Autism Research|October 17, 2018
In Search of Biomarkers for Autism Spectrum DisorderMarta Del Valle Rubido, James T McCracken, Eric Hollander, et al.
Schizophrenia Bulletin|April 7, 2007
Cognitive functioning in the schizophrenia prodromeAndor E Simon, Katja Cattapan-Ludewig, Solange Zmilacher, et al.
Pageof 8